Transforming growth factor-β and the progression of renal disease

被引:223
作者
Loeffler, Ivonne [1 ]
Wolf, Gunter [1 ]
机构
[1] Univ Hosp Jena, Dept Internal Med 3, Jena, Germany
关键词
diabetic nephropathy; EMT; fibroblasts; progression of renal diseases; renal fibrosis; TO-MESENCHYMAL TRANSITION; PROXIMAL TUBULAR CELLS; TGF-BETA; DIABETIC-NEPHROPATHY; II RECEPTOR; MOLECULAR-MECHANISMS; GLOMERULAR-DISEASES; SIGNAL-TRANSDUCTION; KIDNEY-DISEASE; FIBROSIS;
D O I
10.1093/ndt/gft267
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Transforming growth factor-b (TGF-b) is a profibrotic cytokine found in chronic renal diseases, which initiates and modulates a variety of pathophysiological processes. It is synthesized by many renal cell types and exerts its biological functions through a variety of signalling pathways, including the Smad and MAPK pathways. In renal diseases, TGF-b is upregulated and induces renal cells to produce extracellular matrix proteins leading to glomerulosclerosis as well as tubulointerstitial fibrosis. Different types of renal cells undergo different pathophysiological changes induced by TGF-b, leading to apoptosis, hypertrophy and abnormalities of podocyte foot processes, which ultimately result in renal dysfunction. In this review, we describe the effects of TGF-b on different renal cell types and the means by which TGF-b participates in the pathomechanisms of glomerular and tubulointerstitial diseases.
引用
收藏
页码:I37 / I45
页数:10
相关论文
共 56 条
[1]   TGF-β signaling in renal disease [J].
Böttinger, EP ;
Bitzer, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10) :2600-2610
[2]  
Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731
[3]   Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].
Derynck, R ;
Zhang, YE .
NATURE, 2003, 425 (6958) :577-584
[4]   Podocytopathy in Diabetes: A Metabolic and Endocrine Disorder [J].
Diez-Sampedro, Ana ;
Lenz, Oliver ;
Fornoni, Alessia .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 58 (04) :637-646
[5]   Transforming growth factor-β1 (TGF-β1):: A potential recovery signal in the post-ischemic kidney [J].
Docherty, NG ;
Pérez-Barriocanal, F ;
Balboa, NE ;
López-Novoa, JM .
RENAL FAILURE, 2002, 24 (04) :391-406
[6]   Molecular basis of renal fibrosis [J].
Eddy, AA .
PEDIATRIC NEPHROLOGY, 2000, 15 (3-4) :290-301
[7]   Treatment with anti-TGF-β antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-β signaling [J].
Fukasawa, H ;
Yamamoto, T ;
Suzuki, H ;
Togawa, A ;
Ohashi, N ;
Fujigaki, Y ;
Uchida, C ;
Aoki, M ;
Hosono, M ;
Kitagawa, M ;
Hishida, A .
KIDNEY INTERNATIONAL, 2004, 65 (01) :63-74
[8]   Deleting the TGF-β Receptor Attenuates Acute Proximal Tubule Injury [J].
Gewin, Leslie ;
Vadivelu, Sangeetha ;
Neelisetty, Surekha ;
Srichai, Manakan B. ;
Paueksakon, Paisit ;
Pozzi, Ambra ;
Harris, Raymond C. ;
Zent, Roy .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (12) :2001-2011
[9]   Transforming growth factor-β1 in the kidney and urine of patients with glomerular disease and proteinuria [J].
Goumenos, DS ;
Tsakas, S ;
El Nahas, AM ;
Alexandri, S ;
Oldroyd, S ;
Kalliakmani, P ;
Vlachojannis, JG .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (12) :2145-2152
[10]   Insight on the Pathogenesis of Diabetic Nephropathy from the Study of Podocyte and Mesangial Cell Biology [J].
Gruden, Gabriella ;
Perin, Paolo C. ;
Camussi, Giovanni .
CURRENT DIABETES REVIEWS, 2005, 1 (01) :27-40